WOOF for the Cure has established an ongoing collaboration with 11 veterinary oncologists and has now enrolled over 50 canine patients across two studies. Thanks to the many families who have enrolled their pets, WOOF for the Cure has driven the clinical optimization of CIVO and is actively contributing to the development of two investigational drugs.
We continue to work towards our two main goals: (1) to provide oncologists with a technology that will allow them to select optimal anti-cancer drugs and reject ineffective therapies for each patient with confidence and (2) to identify the most promising drug candidates earlier, thus helping define the future of cancer care. We are proud to be able to help our enrolled canine cancer patients and their owners by covering some of the costs associated with their treatment.
- Evaluation of clinical feasibility in canine lymphoma - enrollment temporarily suspended.
Past Studies - Enrollment Complete
- Evaluation of clinical feasibility in canine sarcoma
The WOOF for the Cure study was featured from December to June 2016 as part of an on-going family-friendly exhibit at the Pacific Science Center in Seattle! The movies below were produced by the Pacific Science Center as part of the exhibit, which also features several other exciting research ventures in the Seattle area. For more information about the exhibit, please follow the link below.